基于泪膜动力学的干眼泪膜导向诊断与治疗
本文介绍了日本提出的干眼新概念——泪膜导向诊断(TFOD)与泪膜导向治疗(TFOT)。TFOD通过睁眼后泪膜动力学和泪膜破裂模式(BUPs)将干眼分为水液缺乏型、湿润性下降型和蒸发增加型,并据此进行分层治疗。在日本,泪膜破裂时间异常(≤5秒)和症状被用于干眼诊断,TFOD和TFOT被认为是管理干眼的理想实用路径。
要点
- TFOD通过泪膜破裂模式将干眼分为水液缺乏型、湿润性下降型和蒸发增加型。
- TFOT根据各亚型缺乏的成分(水液、膜相关黏蛋白、脂质层/分泌性黏蛋白)进行补充治疗。
- 日本以泪膜破裂时间≤5秒和症状作为干眼诊断依据,泪膜破裂被视为可见的核心机制。
核心结论
- TFOD和TFOT是基于泪膜动力学对干眼进行分层诊断与治疗的理想实用路径。
研究设计与样本
- 本文为叙述性综述,回顾了日本自2010年12月和2012年1月分别上市3%地夸磷索钠滴眼液和2%瑞巴派特滴眼液以来的干眼诊疗进展。
主要发现
- TFOD通过睁眼后泪膜动力学和泪膜破裂模式对干眼进行鉴别诊断,分为水液缺乏型干眼、湿润性下降型干眼和蒸发增加型干眼。
- 各泪膜破裂模式可分层区分眼表responsible不足成分:水液缺乏型对应水液不足,湿润性下降型对应膜相关黏蛋白(尤其MUC16)不足,蒸发增加型对应脂质层和/或分泌性黏蛋白不足。
- 在日本,泪膜破裂被视为干眼可见的核心机制,异常泪膜破裂时间(≤5秒)和症状目前用于干眼诊断。
关键数值与推荐
- 日本目前采用异常泪膜破裂时间(即≤5秒)和症状用于干眼诊断。
临床怎么用
- 临床可依据泪膜破裂模式和泪膜动力学对干眼进行分层诊断,并针对所缺乏的成分选择现有局部治疗进行补充。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In December 2010 and January 2012, 3% diquafosol sodium ophthalmic solution and 2% rebamipide ophthalmic suspension, respectively, appeared first in Japan as prescription drugs for the treatment of dry eye (DE). Since then, not only the diagnosis and treatment but also the understanding of the pathophysiology of DE have greatly advanced, and a new concept of layer-by-layer diagnosis and treatment for DE, respectively termed "tear-film-oriented diagnosis" (TFOD) and "tear-film-oriented therapy" (TFOT) was born. This new concept is currently in the process of expanding from Japan to other Asian countries. TFOD is the method used for the differential diagnosis of DE, which includes aqueous-deficiency DE (ADDE), decreased wettability DE (DWDE), and increased evaporation DE (IEDE), through the dynamics of tear film (TF) and breakup patterns (BUPs) after the eye is opened. BUPs and/or each diagnosed DE subtype are/is able to distinguish the insufficient components of the ocular surface that are responsible for each BUP in a layer-by-layer fashion. Aqueous fluid, membrane-associated mucins (especially MUC16), and the lipid layer and/or secretory mucins must be insufficient in ADDE, DWDE, and IEDE, respectively, and this allows for a layer-by-layer treatment to be proposed for each BUP via the supplementation of the insufficient components, using the topical therapy currently available. In Japan, TF breakup is regarded as a visible core mechanism for DE, and an abnormal breakup time (i.e., ≤5 seconds) and symptoms are currently used for the diagnosis of DE. Therefore, TFOD and TFOT could be an ideal and practical pathway for clinicians to manage DE.
引用
- Yokoi N, Georgiev GA. Tear Film-Oriented Diagnosis and Tear Film-Oriented Therapy for Dry Eye Based on Tear Film Dynamics. Invest Ophthalmol Vis Sci. 2018. PMID: 30481801. doi:10.1167/iovs.17-23700
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。